Consort Medical

Consort Medical is a healthcare company focused on medical device technologies for drug delivery.

Our strategy moving forward is to build on and strengthen our core businesses through new product innovation, increased market reach and higher value product and service offerings.

We are also diversifying the Group into adjacent markets and technologies which leverage our competencies in medical devices and drug delivery.


  • Like for like operating profit (before special items) up 2.9% to £21.5m;
  • Adjusted EPS from continuing and discontinued operations up 5.2% to 54.9p per share;
  • Development pipeline strengthened with considerable progress in the development of programmes;
  • Successful launch of Chiesi NEXThaler, initially in Germany;
  • New contract for nicotine delivery device including drug handling and pharmaceutical packaging for the customer;
  • Completed divestment of King Systems for a full price before contingent consideration of £79.6m; and
  • Final dividend increased 5.0% to 12.71p, giving a full year dividend of 19.71p, and dividend cover of 2.79x.